Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2010

View Archived Issues

NeuroSearch claims new nicotinic acetylcholine receptor modulators

Monthly and twice-monthly certolizumab pegol equally maintain responses in Crohn's disease patients

Studies reveal activity of DZNep in multiple myeloma and acute myeloid leukemia

RAV-12 antibody to be re-engineered for further clinical testing in cancer

Abbott claims new Rho kinase inhibitors

Novartis discloses novel CRF1 receptor antagonists

Menarini and Ipsen launch febuxostat in France for chronic hyperuricemia in gout

FDA's grant of 5-year market exclusivity to Vyvanse upheld in court

FDA approves CSL Behring's Hizentra immunoglobulin therapy

Avineuro reports phase I results on AVN-322 in Alzheimer's disease

Kapidex renamed Dexilant in U.S.

Doxazosin correlates with improved voiding dysfunction in Parkinson's disease

Bupivacaine alleviates bladder syndrome/interstitial cystitis pain in lidocaine-refractory patients

French scientists disclose new broad-spectrum ricin inhibitors

Isis initiates phase I trial of ISIS-SOD1Rx in patients with ALS

FDA accepts for review Biodel's VIAject NDA for diabetes

Anthera completes initial public offering and prepares A-002 trial

BioSante to raise funds in registered direct offering

ImmuneRegen applies for FDA orphan drug status for Homspera in IPF

Amarillo Biosciences and Intas sign license agreement for oral interferon to treat influenza

Adamis and La Jolla Pharmaceutical terminate merger agreement

Novartis claims novel antiviral agents

Chelsea Therapeutics completes registered direct offering to institutional investors

NicOx's naproxcinod NDA for osteoarthritis to be discussed by FDA advisory committees in May

Avid to present update on phase III clinical trials of AV-45

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...